{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:33:59Z","timestamp":1793727239198,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022072","name":"Universitas Indonesia Fakultas Kedokteran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijid.2026.109198","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:04:29Z","timestamp":1792422269000},"page":"109198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herpes Zoster Vaccination in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis of Vaccine Efficacy, Effectiveness, and Safety"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-2814","authenticated-orcid":false,"given":"Sukamto","family":"Koesnoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Yunihastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvina","family":"Widhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshari Saifuddin","family":"Hasibuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bramantya","family":"Wicaksana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diski","family":"Saisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utariny Nurin","family":"Nasywa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira Laksmi","family":"Maharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109198_bib0001","doi-asserted-by":"crossref","unstructured":"van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B. A systematic literature review of herpes zoster incidence worldwide. Hum Vaccines Immunother. 2021;17:1714\u201332. https:\/\/doi.org\/10.1080\/21645515.2020.1847582","DOI":"10.1080\/21645515.2020.1847582"},{"key":"10.1016\/j.ijid.2026.109198_bib0002","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of Herpes Zoster in Auto-immune and Inflammatory diseases: Implications for Vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0003","article-title":"Prevalence and risk factors of herpes zoster in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"17","author":"Wang","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.109198_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and\/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3947\/ic.2025.0036","article-title":"Post-marketing Surveillance of a Live Attenuated Herpes Zoster Vaccine (SKYZoster\u00ae) in Adults Aged \u226550 Years in Korea","volume":"57","author":"Baik","year":"2025","journal-title":"Infect Chemother [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0006","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0007","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant Zoster Vaccine (Shingrix\u00ae): A Review in Herpes Zoster","volume":"35","author":"Syed","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ijid.2026.109198_bib0008","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.vaccine.2024.03.024","article-title":"Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021\u201323","volume":"42","author":"Stefanizzi","year":"2024","journal-title":"Vaccine [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0009","article-title":"Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis","volume":"15","author":"Zeevaert","year":"2023","journal-title":"Vaccine X [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0010","article-title":"Safety and Immunogenicity of Co-Administration of Herpes Zoster Vaccines with Other Vaccines in Adults: A Systematic Review and Meta-Analysis. Vaccines [Internet]","volume":"13","author":"Rezahosseini","year":"2025","journal-title":"Multidisciplinary Digital Publishing Institute"},{"key":"10.1016\/j.ijid.2026.109198_bib0011","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.3390\/ijms24086967","article-title":"Immunogenicity and Safety of Adjuvanted Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients on Anti-Cellular Biologic Agents or JAK Inhibitors: A Prospective Observational Study","volume":"24","author":"Venerito","year":"2023","journal-title":"Int J Mol Sci [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.24010","article-title":"Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb\/IV Randomized Study","volume":"72","author":"Calabrese","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ijid.2026.109198_bib0014","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7326\/M20-6928","article-title":"The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy: A Randomized Controlled Trial","volume":"174","author":"Curtis","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2026.109198_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978203","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2026.109198_bib0016","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/S2665-9913(25)00313-3","article-title":"Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study","volume":"8","author":"Aikawa","year":"2026","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0017","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/jiaf395","article-title":"Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in \u226550-year-old Adults With Autoimmune Diseases","volume":"232","author":"Constenla","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-025-03565-0","article-title":"Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster","volume":"27","author":"Curtis","year":"2025","journal-title":"Arthritis Res Ther [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/rheumatology\/keaa424","article-title":"Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials","volume":"60","author":"Dagnew","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijid.2026.109198_bib0020","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjae008","article-title":"Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study","volume":"18","author":"Desai","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ijid.2026.109198_bib0021","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ard.2026.01.002","article-title":"Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial","volume":"85","author":"Hawkins","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0022","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciab125","article-title":"Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure","volume":"73","author":"Izurieta","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0023","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ecco-jcc\/jjac040","article-title":"Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease","volume":"16","author":"Khan","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ijid.2026.109198_bib0024","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cgh.2018.10.016","article-title":"Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases","volume":"17","author":"Khan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.cgh.2021.07.023","article-title":"Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease","volume":"20","author":"Khan","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0026","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.vaccine.2021.05.043","article-title":"Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease","volume":"39","author":"Kochhar","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.109198_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70893","article-title":"Comparative Effectiveness of Recombinant Zoster and Live Attenuated Zoster Vaccines in Chronic Inflammatory Skin Diseases: A Retrospective Cohort Study","volume":"98","author":"Lee","year":"2026","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2026.109198_bib0028","doi-asserted-by":"crossref","unstructured":"Lin Y-L, Wang S-I, Wei JC-C. Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative Network. eClinicalMedicine. 2025;85:103319. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103319","DOI":"10.1016\/j.eclinm.2025.103319"},{"key":"10.1016\/j.ijid.2026.109198_bib0029","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.vaccine.2019.03.043","article-title":"Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials","volume":"37","author":"L\u00f3pez-Fauqued","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.109198_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005839","article-title":"Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA","volume":"11","author":"Mayer","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.ijid.2026.109198_bib0031","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1136\/annrheumdis-2019-215925","article-title":"Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial","volume":"78","author":"Mok","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0032","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1016\/S2665-9913(24)00084-5","article-title":"Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial","volume":"6","author":"Park","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0033","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ard.2025.01.045","article-title":"Effectiveness and safety of the recombinant zoster vaccine in individuals \u226550 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study","volume":"84","author":"Rayens","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2026.109198_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70285","article-title":"Recombinant Zoster Vaccine Reduces All-Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune-Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large-Scale Real-World Retrospective Cohort Study","volume":"97","author":"Shih","year":"2025","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2026.109198_bib0035","first-page":"6154","article-title":"Preventive Effectiveness of Recombinant Zoster Vaccine in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors","author":"Tabata","year":"2026","journal-title":"Intern Med"},{"key":"10.1016\/j.ijid.2026.109198_bib0036","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf116","article-title":"Recombinant herpes zoster vaccine lowers shingles complication risk in patients with inflammatory bowel disease","volume":"19","author":"Wang","year":"2025","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1016\/j.ijid.2026.109198_bib0037","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3899\/jrheum.160685","article-title":"Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases","volume":"44","author":"Yun","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijid.2026.109198_bib0038","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3497","article-title":"The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study","volume":"13","author":"Zhang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijid.2026.109198_bib0039","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.109198_bib0040","doi-asserted-by":"crossref","first-page":"225.1","DOI":"10.4049\/jimmunol.198.Supp.225.1","article-title":"A comparison of the immunogenicity of a live attenuated herpes zoster vaccine (ZV) and the recombinant gE\/AS01B candidate vaccine in older adults","volume":"198","author":"Weinberg","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2026.109198_bib0041","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ijid.2026.109198_bib0042","unstructured":"Medeiros-Ribeiro AC, de Oliveira J, Aikawa N, Pasoto S, Kupa L, Saad CGS, et al. Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients Vaccinated with Recombinant Herpes Zoster Vaccine: An Interim Analysis of a Prospective Randomized Phase 4 Study [Internet]. ACR Meet. Abstr. [cited 2026 May 11]. https:\/\/acrabstracts.org\/abstract\/two-week-methotrexate-discontinuation-in-autoimmune-rheumatic-diseases-patients-vaccinated-with-recombinant-herpes-zoster-vaccine-an-interim-analysis-of-a-prospective-randomized-phase-4-study\/. Accessed 11 May 2026"},{"key":"10.1016\/j.ijid.2026.109198_bib0043","article-title":"Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial","volume":"93","author":"Harris","year":"2026","journal-title":"J Infect [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0044","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/14760584.2025.2589216","article-title":"Safety profile and medium- to long-term protection of the Recombinant Zoster Vaccine (RZV) in a cohort of high-risk patients: real-world data from a General Hospital in Southern Italy, 2021\u20132025","volume":"24","author":"Stefanizzi","year":"2025","journal-title":"Expert Rev Vaccines [Internet]"},{"key":"10.1016\/j.ijid.2026.109198_bib0045","article-title":"Recombinant zoster vaccine in patients with inflammatory rheumatic diseases: efficacy, long-term protection and safety under immunosuppression","volume":"12","author":"Krasselt","year":"2026","journal-title":"RMD Open [Internet]"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:05:37Z","timestamp":1793725537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226008337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S1201971226008337"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109198","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes Zoster Vaccination in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis of Vaccine Efficacy, Effectiveness, and Safety","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109198"}}